E-LIB Suche - Ergebnisse für: Okines, A.

1

The emerging predictive and prognostic role of HER2 in HER2..:

Corianò, Matilde ; Tommasi, Chiara ; Dinh, Anh Thi Lan...
Breast Cancer Research and Treatment. 206 (2024) 3 - p. 603-614 , 2024

Link: https://doi.org/10.1007/..

2

Resistance to Targeted Inhibitors of the PI3K/AKT/mTOR Path..:

Browne, Iseult M. ; Okines, Alicia F. C.
Cancers. 16 (2024) 12 - p. 2259 , 2024

Link: https://doi.org/10.3390/..

3

Significance of Complete Metabolic Response to First-line T..:

McGrath, H. ; Foran, C. ; Midgen, A....
Clinical Oncology. 36 (2024) 4 - p. e110 , 2024

Link: https://doi.org/10.1016/..

4

194P Monitoring for pneumonitis due to trastuzumab deruxtec..:

Walker, O. ; Esteban, M. ; Phillips, E.R....
ESMO Open. 9 (2024) - p. 103216 , 2024

Link: https://doi.org/10.1016/..

5

Real world study of sacituzumab govitecan in metastatic tri..:

Hanna, Daire ; Merrick, Sophie ; Ghose, Aruni...
British Journal of Cancer. 130 (2024) 12 - p. 1916-1920 , 2024

Link: https://doi.org/10.1038/..

6

Developing therapies for triple-negative breast cancer subt..:

Okines, Alicia ; Turner, Nicholas
The Lancet Oncology. 25 (2024) 2 - p. 149-151 , 2024

Link: https://doi.org/10.1016/..

7

Supplementary Figure S1 from Comparison of Circulating Tumo..:

Maria Coakley ; Guillermo Villacampa ; Prithika Sritharan...
doi:10.1158/1078-0432.25232567.v1. , 2024

Link: https://doi.org/10.1158/..

8

Supplementary Table S1 from Comparison of Circulating Tumor..:

Maria Coakley ; Guillermo Villacampa ; Prithika Sritharan...
doi:10.1158/1078-0432.25232561.v1. , 2024

Link: https://doi.org/10.1158/..

9

Supplementary Table S5 from Comparison of Circulating Tumor..:

Maria Coakley ; Guillermo Villacampa ; Prithika Sritharan...
doi:10.1158/1078-0432.25232549.v1. , 2024

Link: https://doi.org/10.1158/..

10

Supplementary Table S3 from Comparison of Circulating Tumor..:

Maria Coakley ; Guillermo Villacampa ; Prithika Sritharan...
doi:10.1158/1078-0432.25232555.v1. , 2024

Link: https://doi.org/10.1158/..

11

Supplementary Figure S2 from Comparison of Circulating Tumo..:

Maria Coakley ; Guillermo Villacampa ; Prithika Sritharan...
doi:10.1158/1078-0432.25232564.v1. , 2024

Link: https://doi.org/10.1158/..

12

Supplementary Table S2 from Comparison of Circulating Tumor..:

Maria Coakley ; Guillermo Villacampa ; Prithika Sritharan...
doi:10.1158/1078-0432.25232558.v1. , 2024

Link: https://doi.org/10.1158/..

13

Supplementary Table S6 from Comparison of Circulating Tumor..:

Maria Coakley ; Guillermo Villacampa ; Prithika Sritharan...
doi:10.1158/1078-0432.25232546.v1. , 2024

Link: https://doi.org/10.1158/..

14

Supplementary Table S4 from Comparison of Circulating Tumor..:

Maria Coakley ; Guillermo Villacampa ; Prithika Sritharan...
doi:10.1158/1078-0432.25232552.v1. , 2024

Link: https://doi.org/10.1158/..

15

Corrigendum to "Tucatinib versus placebo added to trastuzum..:

Curigliano, G. ; Mueller, V. ; Borges, V....
Annals of Oncology. 34 (2023) 7 - p. 630 , 2023

Link: https://doi.org/10.1016/..